News

Moderna, Inc. (MRNA) Withdraws Application for COVID-flu Combination Vaccine
Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) ...
Moderna Provides Update on BLA Submission for Combination Vaccine Against Influenza and COVID-19
CAMBRIDGE, MA / ACCESS Newswire / May 21, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U ...
FDA may limit future COVID-19 boosters to seniors, those at higher risk for complications
Top officials with the U.S. Food and Drug Administration are changing the agency's standards for updated COVID-19 booster ...
Medical Marketing & Media3d
FDA to limit COVID boosters, Trump touts ‘Most Favored Nation’ framework
Additionally, the Department of Health and Human Services unveiled the framework for the Most Favored Nation drug pricing ...
Moderna Stock Jumps on New FDA COVID-19 Booster Guidelines
Shares of Moderna surged to lead S&P 500 gainers Tuesday after the Food and Drug Administration issued new guidance for COVID ...
Morningstar11d
FDA Accepts Biologics License Application for Mucopolysaccharidosis II Treatment
announced today that the U.S. Food and Drug Administration has accepted for review the Biologics License Application (BLA) submission by REGENXBIO Inc. (REGENXBIO; Headquarters: Rockville ...
Yahoo Finance4d
Moderna, Inc. (MRNA) Withdraws Application for COVID-flu Combination Vaccine
Moderna, Inc. (NASDAQ:MRNA) today announced that it had voluntarily withdrawn the pending Biologics License Application (BLA) seeking approval for its COVID-19 and Influenza combination vaccine ...